Underwriting Agreements in the Biotechnology Industry

2,317 Contracts & Agreements

Browse by Company

2seventy bio, Inc. (1 contract)
4D Molecular Therapeutics Inc (4)
89bio, Inc. (7)
AbbVie Inc. (6)
ABEONA THERAPEUTICS INC. (7)
ACADIA PHARMACEUTICALS INC (6)
ACCELERON PHARMA INC (6)
Accustem Sciences Inc. (1)
Achaogen, Inc. (4)
ACHIEVE LIFE SCIENCES, INC. (9)
Acorda Therapeutics (5)
Actinium Pharmaceuticals, Inc. (4)
Acumen Pharmaceuticals, Inc. (2)
Acurx Pharmaceuticals, LLC (2)
Adagio Therapeutics, Inc. (1)
Adamas Pharmaceuticals Inc (4)
Adaptimmune Therapeutics PLC (3)
Adhera Therapeutics, Inc. (7)
ADiTx Therapeutics, Inc. (6)
ADMA BIOLOGICS, INC. (10)
ADURO BIOTECH, INC. (3)
Advaxis, Inc. (10)
Adverum Biotechnologies, Inc. (5)
Aeglea BioTherapeutics, Inc. (6)
Aerovate Therapeutics, Inc. (1)
AGENUS INC (3)
AGIOS PHARMACEUTICALS INC (7)
AILERON THERAPEUTICS INC (3)
Aimmune Therapeutics, Inc. (2)
AKCEA THERAPEUTICS, INC. (1)
Akebia Therapeutics, Inc. (6)
Akero Therapeutics, Inc. (5)
Akouos, Inc. (1)
ALBIREO PHARMA, INC. (9)
Aldeyra Therapeutics, Inc. (9)
Alector, Inc. (4)
Alexion Pharmaceuticals (1)
Aligos Therapeutics, Inc. (2)
Alkermes plc. (1)
Allakos Inc. (4)
Allena Pharmaceuticals, Inc. (3)
Alliqua BioMedical, Inc. (2)
Allogene Therapeutics, Inc. (3)
Allovir, Inc. (2)
ALNYLAM PHARMACEUTICALS, INC. (9)
Alpha Healthcare Acquisition Corp. (3)
ALPINE IMMUNE SCIENCES, INC. (3)
Altimmune, Inc. (2)
ALX ONCOLOGY HOLDINGS INC (3)
Alzamend Neuro, Inc. (1)
AMARILLO BIOSCIENCES INC (2)
AMARIN CORP PLC (7)
Amgen Inc. (18)
AMICUS THERAPEUTICS, INC. (7)
AmpliPhi Biosciences Corp (4)
Amplitude Healthcare Acquisition Corp (4)
ANAPTYSBIO INC (4)
Anchiano Therapeutics Ltd. (2)
Anixa Biosciences Inc (1)
Annexon, Inc. (3)
Annovis Bio, Inc. (4)
Apellis Pharmaceuticals, Inc. (7)
APPLIED GENETIC TECHNOLOGIES CORP (6)
Applied Molecular Transport Inc. (2)
Applied Therapeutics Inc. (4)
Aprea Therapeutics, Inc. (2)
Aptevo Therapeutics Inc. (1)
Aptinyx Inc. (2)
Aptose Biosciences Inc. (6)
AquaBounty Technologies, Inc. (10)
AQUINOX PHARMACEUTICALS, INC (5)
Aravive, Inc. (3)
Arbutus Biopharma Corp (1)
ARCA biopharma, Inc. (1)
Arcellx, Inc. (2)
Arcturus Therapeutics Holdings Inc. (3)
Arcus Biosciences, Inc. (2)
Arcutis Biotherapeutics, Inc. (6)
ARDELYX, INC. (4)
ARENA PHARMACEUTICALS INC (7)
Aridis Pharmaceuticals, Inc. (1)
ARROWHEAD PHARMACEUTICALS, INC. (3)
Arsanis, Inc. (4)
Artiva Biotherapeutics, Inc. (2)
ARYA Sciences Acquisition Corp II (5)
ASSEMBLY BIOSCIENCES, INC. (8)
Atara Biotherapeutics, Inc. (8)
Athenex, Inc. (3)
ATHERSYS, INC (2)
ATOSSA GENETICS INC (7)
Atreca, Inc. (2)
aTYR PHARMA INC (3)
Aura Biosciences, Inc. (3)
AVEO PHARMACEUTICALS INC (5)
Avid Bioservices, Inc. (3)
Avidity Biosciences, Inc. (3)
Avita Therapeutics, Inc. (1)
AVROBIO, Inc. (4)
Axcella Health Inc. (2)
Axovant Sciences Ltd. (5)
Ayala Pharmaceuticals, Inc. (2)
AZIYO BIOLOGICS, INC. (2)
AzurRx BioPharma, Inc. (4)
BCTG Acquisition Corp. (2)
Beam Therapeutics Inc. (2)
BeiGene, Ltd. (7)
BELLICUM PHARMACEUTICALS, INC (5)
Benitec Biopharma Inc. (7)
BICYCLE THERAPEUTICS Ltd (3)
Big Cypress Acquisition Corp. (2)
BIO-PATH HOLDINGS INC (1)
bioAffinity Technologies, Inc. (18)
BioAtla, Inc. (2)
BioCardia, Inc. (4)
BIOCEPT INC (8)
BIOCRYST PHARMACEUTICALS INC (8)
Biogen Inc. (2)
Biohaven Pharmaceutical Holding Co Ltd. (5)
BioLife4D Corp (4)
BIOMARIN PHARMACEUTICAL INC (6)
Biomea Fusion, Inc. (2)
BioNexus Gene Lab Coporation (2)
BioRestorative Therapies, Inc. (5)
Biostage, Inc. (2)
BIOTIME INC (5)
BIOVIE INC. (4)
BioXcel Therapeutics, Inc. (6)
Bison Capital Acquisition Corp. (2)
Black Diamond Therapeutics, Inc. (2)
Blue Water Vaccines Inc. (3)
bluebird bio, Inc. (11)
Blueprint Medicines Corp (6)
Bolt Biotherapeutics, Inc. (1)
Bone Biologics Corp (9)
BRAINSTORM CELL THERAPEUTICS INC. (2)
BriaCell Therapeutics Corp. (1)
BridgeBio Pharma, Inc. (4)
BullFrog AI Holdings, Inc. (5)
C4 Therapeutics, Inc. (2)
Cabaletta Bio, Inc. (3)
CALADRIUS BIOSCIENCES, INC. (5)
Calithera Biosciences, Inc. (5)
Calyxt, Inc. (6)
CANCER GENETICS, INC (9)
Candel Therapeutics, Inc. (2)
CAPRICOR THERAPEUTICS, INC. (2)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (2)
CareDx, Inc. (5)
Caribou Biosciences, Inc. (2)
CASTLE BIOSCIENCES INC (3)
CATABASIS PHARMACEUTICALS INC (9)
CATALYST BIOSCIENCES, INC. (8)
CATALYST PHARMACEUTICALS, INC. (9)
CEL SCI CORP (9)
Celcuity Inc. (3)
Celldex Therapeutics, Inc. (9)
Cellectar Biosciences, Inc. (7)
Cellular Biomedicine Group, Inc. (1)
Celsion CORP (3)
Centessa Pharmaceuticals Ltd (3)
Century Therapeutics, Inc. (1)
Chanticleer Holdings, Inc. (13)
Chardan Healthcare Acquisition 2 Corp. (2)
Chardan Healthcare Acquisition Corp. (2)
Checkmate Pharmaceuticals, Inc. (1)
Checkpoint Therapeutics, Inc. (3)
Chelsea Worldwide Inc. (1)
ChemoCentryx, Inc. (3)
CHIMERIX INC (7)
Cibus Global, Ltd. (1)
Cidara Therapeutics, Inc. (6)
CLEVELAND BIOLABS INC (2)
Clovis Oncology, Inc. (9)
CM Life Sciences III Inc. (2)
Codiak BioSciences, Inc. (3)
CohBar, Inc. (2)
Coherus BioSciences, Inc. (6)
Conatus Pharmaceuticals Inc. (3)
CONCERT PHARMACEUTICALS, INC. (4)
Consonance-HFW Acquisition Corp. (2)
Constellation Alpha Capital Corp. (6)
CONSTELLATION PHARMACEUTICALS INC (3)
CONTRAFECT Corp (6)
Corbus Pharmaceuticals Holdings, Inc. (4)
Cortexyme, Inc. (1)
Corvus Pharmaceuticals, Inc. (3)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (3)
Crinetics Pharmaceuticals, Inc. (7)
CRISPR Therapeutics AG (5)
CTD HOLDINGS INC (4)
CTI BIOPHARMA CORP (7)
Cue Biopharma, Inc. (2)
Cullinan Oncology, LLC (1)
Curative Biotechnology Inc (1)
CURIS INC (3)
Cyclacel Pharmaceuticals, Inc. (9)
Cytokinetics, Incorporated (8)
CytomX Therapeutics, Inc. (3)
CYTORI THERAPEUTICS, INC. (4)
CYTRX CORP (5)
Day One Biopharmaceuticals Holding Co LLC (3)
Decibel Therapeutics, Inc. (1)
Deciphera Pharmaceuticals, Inc. (6)
DelMar Pharmaceuticals, Inc. (3)
Denali Therapeutics Inc. (3)
Dermavant Sciences Ltd (1)
Dermira, Inc. (5)
Design Therapeutics, Inc. (1)
DiaMedica Therapeutics Inc. (4)
Dicerna Pharmaceuticals Inc (4)
Diffusion Pharmaceuticals Inc. (4)
Dynamics Special Purpose Corp. (2)
DYNAVAX TECHNOLOGIES CORP (9)
Dyne Therapeutics, Inc. (4)
Edge Therapeutics, Inc. (4)
Editas Medicine, Inc. (6)
Eidos Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (7)
Elevation Oncology, Inc. (2)
Eliem Therapeutics, Inc. (1)
Enanta Pharmaceuticals, Inc. (1)
Entasis Therapeutics Holdings Inc. (1)
Entrada Therapeutics, Inc. (1)
Environmental Impact Acquisition Corp (2)
Epizyme, Inc. (9)
Equillium, Inc. (2)
Erasca, Inc. (3)
Esperion Therapeutics, Inc. (3)
ESSA Pharma Inc. (1)
Evelo Biosciences, Inc. (2)
EXACT SCIENCES CORP (4)
Exelixis (8)
EXICURE, INC. (2)
FATE THERAPEUTICS INC (8)
FENNEC PHARMACEUTICALS INC. (3)
Fibrocell Science, Inc. (4)
FIBROGEN INC (3)
Finch Therapeutics Group, Inc. (1)
FIVE PRIME THERAPEUTICS INC (5)
Flex Pharma, Inc. (6)
Flexion Therapeutics Inc (4)
Foghorn Therapeutics Inc. (2)
Forma Therapeutics Holdings, Inc., (2)
Fortress Biotech, Inc. (8)
Forty Seven, Inc. (3)
Frequency Therapeutics, Inc. (1)
FS Development Corp. (4)
FS Development Corp. II (2)
Fusion Pharmaceuticals Inc. (1)
G1 Therapeutics, Inc. (4)
Gain Therapeutics, Inc. (4)
GALECTIN THERAPEUTICS INC (1)
Galecto Inc. (1)
Galera Therapeutics, Inc. (1)
Gamida Cell Ltd. (2)
Gemphire Therapeutics Inc. (5)
GENELUX CORP (2)
Generation Bio Co. (2)
GENOCEA BIOSCIENCES, INC. (7)
Genprex, Inc. (2)
GeoVax Labs, Inc. (4)
GERON CORP (8)
Gilead Sciences (10)
Global Blood Therapeutics, Inc. (6)
GLYCOMIMETICS INC (4)
Gossamer Bio, Inc. (4)
Grail, Inc. (1)
Graphite Bio, Inc. (2)
Greenwich LifeSciences, Inc. (5)
Gritstone Oncology, Inc. (3)
GT Biopharma, Inc. (1)
GTX INC (3)
GX Acquisition Corp. (4)
HALOZYME THERAPEUTICS INC (4)
Harpoon Therapeutics, Inc. (2)
HCW Biologics Inc. (1)
Health Sciences Acquisitions Corp (6)
HEAT BIOLOGICS, INC. (18)
HEMISPHERX BIOPHARMA INC (2)
HERON THERAPEUTICS, INC. (9)
HilleVax, Inc. (2)
Hillstream BioPharma Inc. (3)
HISTOGENICS CORP (5)
Homology Medicines, Inc. (3)
HOOKIPA Pharma Inc. (4)
HUMANIGEN, INC (4)
iBio, Inc. (11)
Icosavax, Inc. (1)
IDEAYA Biosciences, Inc. (6)
IDERA PHARMACEUTICALS, INC. (3)
IGM Biosciences, Inc. (4)
Imago BioSciences, Inc. (1)
Immix Biopharma, Inc. (3)
IMMUCELL CORP (2)
IMMUNE PHARMACEUTICALS INC (2)
Immuneering Corp (2)
ImmunoCellular Therapeutics, Ltd. (9)
IMMUNOGEN INC (8)
Immunome Inc. (2)
IMMUNOMEDICS INC (6)
IMPEL NEUROPHARMA INC (2)
IN8BIO, INC. (4)
Incyte (3)
INFINITY PHARMACEUTICALS, INC. (3)
Inhibikase Therapeutics, Inc. (3)
Inhibrx, Inc. (1)
InMed Pharmaceuticals Inc. (3)
Inmune Bio, Inc. (1)
INOVIO PHARMACEUTICALS, INC. (5)
Inozyme Pharma, Inc. (3)
INSMED Inc (12)
Inspyr Therapeutics, Inc. (1)
Instil Bio, Inc. (1)
Intec Pharma Ltd. (1)
Intellia Therapeutics, Inc. (6)
INTERCEPT PHARMACEUTICALS, INC. (7)
INTREXON CORP (9)
Intrinsic Medicine, Inc. (1)
Invitae Corp (6)
IONIS PHARMACEUTICALS INC (2)
IOVANCE BIOTHERAPEUTICS, INC. (9)
IRONWOOD PHARMACEUTICALS INC (5)
Isoray, Inc. (6)
iTeos Therapeutics, Inc. (1)
Janux Therapeutics, Inc. (4)
Jounce Therapeutics, Inc. (1)
Kadmon Holdings, Inc. (3)
KalVista Pharmaceuticals, Inc. (5)
Karuna Therapeutics, Inc. (4)
Karyopharm Therapeutics Inc. (6)
KBL MERGER CORP. IV (1)
Keros Therapeutics, Inc. (3)
Kezar Life Sciences, Inc. (3)
Kindred Biosciences, Inc. (6)
Kiniksa Pharmaceuticals, Ltd. (3)
Kinnate Biopharma Inc. (1)
Kiromic Biopharma, Inc. (4)
Kodiak Sciences Inc. (3)
Kronos Bio, Inc. (1)
Krystal Biotech, Inc. (6)
Kura Oncology, Inc. (7)
Kymera Therapeutics, Inc. (4)
LA JOLLA PHARMACEUTICAL CO (4)
Lantern Pharma Inc. (2)
LEAP THERAPEUTICS, INC. (4)
Leisure Acquisition Corp. (4)
LEXICON PHARMACEUTICALS, INC. (4)
LianBio (1)
LifeSci Acquisition Corp. (3)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (1)
Locust Walk Acquisition Corp. (2)
LogicBio Therapeutics, Inc. (2)
LONGEVERON LLC (2)
Lyell Immunopharma, Inc. (1)
MACROGENICS INC (5)
MADRIGAL PHARMACEUTICALS, INC. (9)
Magenta Therapeutics, Inc. (4)
MAIA Biotechnology, Inc. (8)
MANNKIND CORP (4)
MARIZYME INC (2)
Marker Therapeutics, Inc. (1)
MATEON THERAPEUTICS INC (1)
Matinas BioPharma Holdings, Inc. (2)
MAXCYTE, INC. (1)
MEDICINOVA INC (4)
Medovex Corp. (6)
MEI Pharma, Inc. (5)
MeiraGTx Holdings plc (4)
MERRIMACK PHARMACEUTICALS INC (3)
Mersana Therapeutics, Inc. (3)
Merus N.V. (4)
Metacrine, Inc. (1)
Millendo Therapeutics, Inc. (4)
MiMedx Group, Inc. (1)
Minerva Neurosciences, Inc. (3)
MiNK Therapeutics, Inc. (1)
MIRAGEN THERAPEUTICS, INC. (8)
Mirati Therapeutics, Inc. (13)
Mirum Pharmaceuticals, Inc. (4)
Moderna, Inc. (3)
Molecular Templates, Inc. (5)
Moleculin Biotech, Inc. (5)
Momenta Pharmaceuticals, Inc. (5)
Monopar Therapeutics (1)
Monte Rosa Therapeutics, Inc. (2)
Morphic Holding, Inc. (3)
MUSTANG BIO, INC. (2)
Myovant Sciences Ltd. (3)
Myriad Genetics, Inc. (1)
NANOVIRICIDES, INC. (3)
NantKwest, Inc. (3)
Natera, Inc. (8)
NAVIDEA BIOPHARMACEUTICALS, INC. (3)
NEUROBIOLOGICAL TECHNOLOGIES INC (1)
NEUROCRINE BIOSCIENCES INC (4)
NEWLINK GENETICS CORP (3)
NexImmune, Inc. (1)
NextCure, Inc. (2)
Nkarta, Inc. (3)
NORTHWEST BIOTHERAPEUTICS INC (3)
NOVAVAX INC (6)
Novus Therapeutics, Inc. (2)
NTN BUZZTIME INC (1)
Nurix Therapeutics, Inc. (3)
Nuvalent, Inc. (4)
Nuvectis Pharma, Inc. (3)
Ohr Pharmaceutical Inc (3)
Olema Pharmaceuticals, Inc. (1)
Olivia Ventures, Inc. (2)
Omega Therapeutics, Inc. (1)
OncoCyte Corp (1)
Oncorus, Inc. (2)
ONCOSEC MEDICAL Inc (2)
OPGEN INC (5)
Ophthotech Corp. (7)
Opko Health, Inc. (2)
ORAGENICS INC (7)
Organogenesis Holdings Inc. (3)
ORGANOVO HOLDINGS, INC. (3)
Oric Pharmaceuticals, Inc. (2)
Outlook Therapeutics, Inc. (6)
Ovid Therapeutics Inc. (6)
Oyster Point Pharma, Inc. (2)
PALATIN TECHNOLOGIES INC (2)
Pasithea Therapeutics Corp. (2)
Passage BIO, Inc. (2)
PDL BIOPHARMA, INC. (4)
PepGen Inc. (2)
Petra Acquisition Inc. (5)
Pfenex Inc. (4)
PharmaCyte Biotech, Inc. (1)
PhaseBio Pharmaceuticals Inc (3)
Phio Pharmaceuticals Corp. (7)
PIERIS PHARMACEUTICALS, INC. (2)
PLURISTEM THERAPEUTICS INC (5)
PMV Pharmaceuticals, Inc. (1)
POLARITYTE, INC. (5)
PORTOLA PHARMACEUTICALS INC (7)
Poseida Therapeutics, Inc. (1)
Praxis Precision Medicines, Inc. (3)
PRECISION BIOSCIENCES INC (3)
Prelude Therapeutics Inc (3)
Prevail Therapeutics Inc. (1)
Principia Biopharma Inc. (2)
Progenics Pharmaceuticals, Inc. (7)
PROGENITY, INC. (3)
Prometheus Biosciences, Inc. (2)
Protagenic Therapeutics, Inc. (2)
Protagonist Therapeutics, Inc (6)
Protalix BioTherapeutics, Inc. (3)
PROTEON THERAPEUTICS INC (4)
PROTEOSTASIS THERAPEUTICS, INC. (4)
Prothena Corp plc (8)
PTC THERAPEUTICS, INC. (6)
PUMA BIOTECHNOLOGY, INC. (4)
Pyxis Oncology, Inc. (1)
Radius Health, Inc. (6)
Rallybio Corp (2)
RAPT Therapeutics, Inc. (5)
RECURSION PHARMACEUTICALS, INC. (2)
Regeneron Pharmaceuticals (4)
REGENXBIO Inc. (5)
Regulus Therapeutics Inc. (4)
Relay Therapeutics, Inc. (4)
Reneo Pharmaceuticals, Inc. (2)
RenovoRx, Inc. (2)
Repare Therapeutics Inc. (1)
Replimune Group, Inc. (5)
Retrophin, Inc. (8)
Revolution Medicines, Inc. (6)
REXAHN PHARMACEUTICALS, INC. (2)
Rezolute, Inc. (3)
RHYTHM PHARMACEUTICALS, INC. (5)
RIGEL PHARMACEUTICALS INC (9)
RITTER PHARMACEUTICALS INC (2)
ROCKET PHARMACEUTICALS, INC. (12)
Rubius Therapeutics, Inc. (2)
Sage Therapeutics, Inc. (7)
Sana Biotechnology, Inc. (2)
SANGAMO THERAPEUTICS, INC (6)
Sarepta Therapeutics, Inc. (7)
Savara Inc (9)
Scholar Rock Holding Corp (4)
SEATTLE GENETICS INC (4)
SELECTA BIOSCIENCES INC (3)
SELLAS Life Sciences Group, Inc. (13)
Sensei Biotherapeutics, Inc. (1)
SERA PROGNOSTICS, INC. (1)
Seres Therapeutics, Inc. (3)
Sesen Bio, Inc. (6)
Shattuck Labs, Inc. (2)
Shuttle Pharmaceuticals Holdings, Inc. (6)
Sierra Oncology, Inc. (5)
Sigilon Therapeutics, Inc. (1)
Silverback Therapeutics, Inc. (1)
Social Capital Suvretta Holdings Corp. III (3)
SOLENO THERAPEUTICS INC (11)
Solid Biosciences Inc. (2)
SOLIGENIX, INC. (2)
SOPHIRIS BIO INC. (1)
Sorrento Therapeutics, Inc. (4)
Spectrum Pharmaceuticals, Inc. (1)
Spero Therapeutics, Inc. (4)
SPHERIX INC (4)
Spinning Eagle Acquisition Corp. (3)
Spring Bank Pharmaceuticals, Inc. (5)
SpringWorks Therapeutics, Inc. (3)
SPRUCE BIOSCIENCES, INC. (1)
SQZ Biotechnologies Co (2)
Stellar Biotechnologies, Inc. (1)
Stoke Therapeutics, Inc. (3)
Sun BioPharma, Inc. (5)
SUNESIS PHARMACEUTICALS INC (13)
Sunshine Biopharma, Inc (5)
Surface Oncology, Inc. (1)
SUTRO BIOPHARMA, INC. (4)
Syndax Pharmaceuticals Inc (7)
SYNLOGIC, INC. (6)
Synthetic Biologics, Inc. (6)
Syros Pharmaceuticals, Inc. (6)
T2 Biosystems, Inc. (5)
Talaris Therapeutics, Inc. (2)
Taysha Gene Therapies, Inc. (4)
TCR2 THERAPEUTICS INC. (3)
TENAX THERAPEUTICS, INC. (2)
Tenaya Therapeutics, Inc. (3)
TG THERAPEUTICS, INC. (4)
Therapeutics Acquisition Corp. (3)
Tocagen Inc (3)
Tonix Pharmaceuticals Holding Corp. (16)
Tracon Pharmaceuticals, Inc. (3)
Transcode Therapeutics, Inc. (5)
Translate Bio, Inc. (3)
TREVENA INC (4)
Trovagene, Inc. (4)
TScan Therapeutics, Inc. (3)
Turning Point Therapeutics, Inc. (4)
Twist Bioscience Corp (6)
TYME TECHNOLOGIES, INC. (2)
Tyra Biosciences, Inc. (1)
U.S. Stem Cell, Inc. (1)
Ultragenyx Pharmaceutical Inc. (9)
Unicycive Therapeutics, Inc. (2)
uniQure N.V. (3)
Unity Biotechnology, Inc. (2)
Unum Therapeutics Inc. (5)
UroGen Pharma Ltd. (2)
VACCINEX, INC. (1)
Vaccitech plc (1)
Vanda Pharmaceuticals Inc. (3)
Vaxart, Inc. (4)
Vaxcyte, Inc. (6)
Vaxxinity, Inc. (2)
VBI Vaccines Inc (5)
Vera Therapeutics, Inc. (5)
VERACYTE, INC. (7)
Verastem, Inc. (7)
Vericel Corp (8)
Vertex Pharmaceuticals Inc (4)
Verve Therapeutics, Inc. (3)
VICAL INC (7)
Viela Bio, Inc. (2)
Vigil Neuroscience, Inc. (1)
Viking Therapeutics, Inc. (9)
Vir Biotechnology, Inc. (2)
Virios Therapeutics, LLC (2)
VistaGen Therapeutics, Inc. (8)
VITAL THERAPIES INC (6)
VITRO DIAGNOSTICS INC (2)
Vor Biopharma Inc. (2)
Voyager Therapeutics, Inc. (3)
vTv Therapeutics Inc. (1)
Werewolf Therapeutics, Inc. (1)
WINDTREE THERAPEUTICS INC (9)
XBiotech Inc. (1)
Xencor Inc (5)
Xenetic Biosciences, Inc. (4)
Xenon Pharmaceuticals Inc. (8)
Xilio Therapeutics, Inc. (1)
XOMA Corp (6)
Y-mAbs Therapeutics, Inc. (2)
YIELD10 BIOSCIENCE, INC. (13)
Yulong Eco-Materials Ltd (2)
ZAFGEN, INC. (5)
Zai Lab Ltd (3)
Zentalis Pharmaceuticals, LLC (5)
ZIOPHARM ONCOLOGY INC (6)
Zymeworks Inc. (2)

Recent Contracts

Underwriting Agreement, dated December 12, 2024, by and among Inovio Pharmaceuticals, Inc., Oppenheimer & Co. Inc. and Citizens JMP Securities LLC (INOVIO PHARMACEUTICALS, INC., Filed With SEC on December 16, 2024)
Underwriting Agreement dated December 12, 2024 (Candel Therapeutics, Inc., Filed With SEC on December 13, 2024)
Underwriting Agreement dated December 11, 2024, between the Company and ThinkEquity LLC (BriaCell Therapeutics Corp., Filed With SEC on December 13, 2024)
Underwriting Agreement, dated December 10, 2024, among Rocket Pharmaceuticals, Inc. and Morgan Stanley & Co. LLC, Leerink Partners LLC and Cantor Fitzgerald & Co., as... (ROCKET PHARMACEUTICALS, INC., Filed With SEC on December 12, 2024)
Underwriting Agreement, dated December 9, 2024, by and among the Company, TD Securities (USA) LLC, Cantor Fitzgerald & Co. and LifeSci Capital LLC (PROTEON THERAPEUTICS INC, Filed With SEC on December 11, 2024)
Underwriting Agreement, dated as of December 10, 2024 by and among the Company, Jefferies LLC, Piper Sandler & Co., as representatives of the underwriters (NantKwest, Inc., Filed With SEC on December 11, 2024)
Underwriting Agreement, dated December 4, 2024, by and among Janux Therapeutics, Inc. and BofA Securities, Inc., TD Securities (USA) LLC, Stifel, Nicolaus & Company, Incorporated,... (Janux Therapeutics, Inc., Filed With SEC on December 5, 2024)
Underwriting Agreement, dated as of December 3, 2024, among Revolution Medicines, Inc. and J.P. Morgan Securities LLC, TD Securities (USA) LLC, Goldman Sachs & Co. LLC and... (Revolution Medicines, Inc., Filed With SEC on December 5, 2024)
Underwriting Agreement dated November 25, 2024 (Replimune Group, Inc., Filed With SEC on November 27, 2024)
Underwriting Agreement, dated November 22, 2024, between the Company and Canaccord Genuity LLC (BioXcel Therapeutics, Inc., Filed With SEC on November 25, 2024)
Underwriting Agreement, dated November 13, 2024, among the Company and Barclays Capital Inc. and BofA Securities, Inc., as representatives of the several underwriters listed in... (Gilead Sciences, Filed With SEC on November 20, 2024)
Underwriting Agreement, by and among the Company and (Aeglea BioTherapeutics, Inc., Filed With SEC on November 19, 2024)
Underwriting Agreement, dated November 14, 2024, by and among the Company and the Underwriters (Zai Lab Ltd, Filed With SEC on November 15, 2024)
Underwriting Agreement, dated as of November 12, 2024, by and among 89bio, Inc., Goldman Sachs & Co. LLC, Leerink Partners LLC and Evercore Group L.L.C (89bio, Inc., Filed With SEC on November 14, 2024)
Underwriting Agreement, dated November 7, 2024, by and among Travere Therapeutics, Inc., Jefferies LLC and Leerink Partners LLC (Retrophin, Inc., Filed With SEC on November 8, 2024)
Underwriting Agreement, dated November 6, 2024, between the Company and Chardan Capital Markets, LLC (Chanticleer Holdings, Inc., Filed With SEC on November 8, 2024)
Form of Underwriting Agreement (Chanticleer Holdings, Inc., Filed With SEC on November 6, 2024)
Underwriting Agreement by and among KalVista Pharmaceuticals, Inc. and Jefferies LLC, BofA Securities, Inc., TD Securities (USA) LLC and Stifel Nicolaus & Company, Incorporated,... (KalVista Pharmaceuticals, Inc., Filed With SEC on November 4, 2024)
Underwriting Agreement by and among the Company, J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Evercore Group L.L.C. and Cantor Fitzgerald & Co., dated October 29, 2024 (Vera Therapeutics, Inc., Filed With SEC on October 31, 2024)
Underwriting Agreement, dated October 29, 2024, by and between Eledon Pharmaceuticals, Inc. and Leerink Partners LLC, as representative of the several underwriters named therein (Novus Therapeutics, Inc., Filed With SEC on October 30, 2024)
Underwriting Agreement, dated October 16, 2024, by and among Capricor Therapeutics, Inc., Piper Sandler & Co. and Oppenheimer & Co. Inc (CAPRICOR THERAPEUTICS, INC., Filed With SEC on October 17, 2024)
Underwriting Agreement, dated October 8, 2024 (Scholar Rock Holding Corp, Filed With SEC on October 10, 2024)
Underwriting Agreement, dated October 8, 2024, by and among Crinetics Pharmaceuticals, Inc. and Leerink Partners LLC and Morgan Stanley & Co. LLC, as representatives of the... (Crinetics Pharmaceuticals, Inc., Filed With SEC on October 9, 2024)
Underwriting Agreement, dated September 26, 2024, by and between Cue Biopharma, Inc. and Oppenheimer & Co. Inc., as representative of the underwriters named therein (Cue Biopharma, Inc., Filed With SEC on September 27, 2024)
Underwriting Agreement, dated as of September 18, 2024, among Cibus, Inc., Roth Capital Partners and A.G.P./Alliance Global Partners, as representatives of the several... (Calyxt, Inc., Filed With SEC on September 19, 2024)
Underwriting Agreement, dated September 16, 2024, by and among the Company, J.P. Morgan Securities LLC, TD Securities (USA) LLC, Jefferies LLC and Stifel, Nicolaus & Company,... (Nuvalent, Inc., Filed With SEC on September 17, 2024)
Underwriting Agreement dated September 12, 2024 (Centessa Pharmaceuticals Ltd, Filed With SEC on September 13, 2024)
Underwriting Agreement, dated September 9, 2024 (IONIS PHARMACEUTICALS INC, Filed With SEC on September 12, 2024)
Underwriting Agreement, by and among the Company and the Representatives, dated as of September 11, 2024 (MIRAGEN THERAPEUTICS, INC., Filed With SEC on September 12, 2024)
Underwriting Agreement, dated September 10, 2024, by and among Xencor, Inc. and Leerink Partners LLC, Raymond James & Associates, Inc. and RBC Capital Markets, LLC, as... (Xencor Inc, Filed With SEC on September 12, 2024)
Underwriting Agreement, dated as of September 10, 2024, by and among the Company, Goldman Sachs & Co. LLC and TD Securities (USA) LLC, as representatives of the several... (Relay Therapeutics, Inc., Filed With SEC on September 11, 2024)
Underwriting Agreement, dated September 4, 2024 (Vaxcyte, Inc., Filed With SEC on September 6, 2024)
Form of Underwriting Agreement (VITRO DIAGNOSTICS INC, Filed With SEC on September 5, 2024)
Underwriting Agreement, dated August 19, 2024, by and among Kymera Therapeutics, Inc. and Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, TD Securities (USA) LLC and Stifel,... (Kymera Therapeutics, Inc., Filed With SEC on August 20, 2024)
Underwriting Agreement, dated as of August 16, 2024, by and between Scorpius Holdings, Inc. and ThinkEquity LLC as Representative of the several Underwriters (HEAT BIOLOGICS, INC., Filed With SEC on August 19, 2024)
Underwriting Agreement dated August 13, 2024 (ANAPTYSBIO INC, Filed With SEC on August 14, 2024)
Underwriting Agreement, dated August 12, 2024, by and among the Company and BofA Securities, Inc (MeiraGTx Holdings plc, Filed With SEC on August 13, 2024)
Underwriting Agreement, dated August 7, 2024, between Precigen, Inc. and Stifel, Nicolaus & Company, Incorporated (INTREXON CORP, Filed With SEC on August 9, 2024)
Form of Underwriting Agreement by and between Scorpius Holdings, Inc. and ThinkEquity LLC (HEAT BIOLOGICS, INC., Filed With SEC on August 1, 2024)
Underwriting Agreement, dated July 31, 2024, by and between Ocugen, Inc. and Titan Partners Group LLC, a division of American Capital Partners, LLC (HISTOGENICS CORP, Filed With SEC on August 1, 2024)